Plainsboro, N.J.-based Integra LifeSciences announced full commercial availability of its Cadence Total Ankle system.
Here are five things to know:
1. The Cadence Total Ankle System was developed in partnership with Tim Daniels, MD, of the University of Toronto; David Pedowitz, MD, of Philadelphia-based The Rothman Institute; Selene Parekh, MD, of Durham, N.C.-based Duke Health; and Christopher Hyer, DPM, of Westerville, Ohio-based Orthopedic Foot & Ankle Center.
2. Over 200 Cadence total ankle procedures have been performed in seven countries in just over a year.
3. No posterior tibial fractures have occurred in over 100 procedures since an FDA recall required the company to implement clarified surgical techniques.
4. Dr. Daniels said, "The streamlined and reliable operative instruments and techniques of this procedure, combined with an anatomical design, offer significant advantages over other ankle systems on the market today."
5. The Cadence system is fully available in the U.S., Canada and several European countries after initially only being available in a limited market release.
More articles on devices:
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2016? 28 things to know
Integra LifeSciences to distribute devices in India — 4 notes
Orthopedic navigations systems market to reach 303.7M: 5 key notes